Assembly Biosciences, Inc. (ASMB) stock forecast and price target
Price $21.12 · data as of November 13, 2026
12-month price target
Average target$51.20
Upside / downside+142.4%
Analysts5
ConsensusStrong buy
Low $43.00Average $51.20High $62.00
Gold marker: average target · white marker: today’s price ($21.12)
Analyst ratings
Strong buy 0Buy 5Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.12 | +78.6% | $71M |
| Next fiscal year ends December 31, 2027 | $-2.57 | −2086.0% | $34M |
| Next quarter ends December 31, 2026 | $0.85 | −65.7% | $42M |
| Quarter after ends March 31, 2027 | $0.02 | +103.7% | $17M |
Consensus of the analysts covering Assembly Biosciences, updated daily. In the last 30 days 2 estimates were raised and 0 lowered.
Frequently asked questions
What is the Assembly Biosciences stock price target?
The average 12-month target from 5 analysts is $51.20, 142.4% above the current price of $21.12 Targets range from $43.00 to $62.00.
Is Assembly Biosciences a buy according to analysts?
The consensus rating is “Strong buy” (5 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Assembly Biosciences expected to earn?
Analysts expect EPS of $-0.12 for the fiscal year ending December 31, 2026 and $-2.57 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.